Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorder-Reference-Cited by-同舟云学术

Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorder

Published:2024-04-18 Issue: Volume: Page:1-14
ISSN:1472-8214
Container-title:Expert Opinion on Emerging Drugs
language:en
Short-container-title:Expert Opinion on Emerging Drugs

Author:

Köhne Sophie¹^ORCID,Hillemacher Thomas²,Glahn Alexander¹,Bach Patrick³⁴

Affiliation:

1. Department of Psychiatry, Social Psychiatry and Psychotherapy, Medical School Hannover, Hannover, Germany

2. Department of Psychiatry and Psychotherapy, Paracelsus Medical University Nuremberg, Nürnberg, Germany

3. Department of Addictive Behavior and Addiction Medicine, Central Institute of Mental Health, Medical Faculty Mannheim. Heidelberg University, Heidelberg, Germany

4. Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728214.2024.2342951

Reference136 articles.

1. Advances in the science and treatment of alcohol use disorder

2. Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016;Griswold MG;The Lancet,2018

3. State-of-the-art behavioral and pharmacological treatments for alcohol use disorder

5. Modeling the impact of alcohol dependence on mortality burden and the effect of available treatment interventions in the European Union;Rehm J;Eur Neuropsychopharmacol,2013

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Conditional Inhibition of Eip75B Eliminates the Effects of Mating and Mifepristone on Lifespan in Female Drosophila;Cells;2024-06-28